Bioceltix is a biotech start-up which deals with the development of stem cell-based medicinal products for veterinary use. Currently, our main goal is to implement a biopharmaceuticals based on allogenic stem cells. The medicines will be primarily to serve the treatment of accompanying animals.
The new product candidates will become a milestone in the field of stem cell-based biopharmaceuticals for veterinary use.
As one of the first such Europe-based company, Bioceltix product intends to go through the full registration path to a marketed drugs devised by the European Medicines Agency (EMA). In the first place, there will be a clinical trials carried out, while the positive results of it will allow us for the submissions of an applications for marketing authorization for the drugs we are developing in the territory of the E.U.
More about products, technology, R&D, team at Bioceltix.com.
Company Details
- Employees
- 35
- Address
- Bierutowska 57-59, Bud. Iii,poland
- Phone
- +48 71 725 34 10
- of****@****tix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioceltix.com
- HQ
- Wrocław, Woj. Dolnośląskie
Bioceltix Questions
Bioceltix's helpline number is +48 71 725 34 10
Bioceltix's website is bioceltix.com
Bioceltix's LinkedIn profile is https://pl.linkedin.com/company/bioceltixcom
Bioceltix has
35 employees.
View email and phone details for 35
employees at Bioceltix.
Bioceltix's industry is
Biotechnology Research
Bioceltix's top competitors are
Pure Biologics,
Bioton S.a.,
Ryvu Therapeutics,
Polpharma Biologics,
Selvita,
Molecure,
Genxone S.a.,
Genomtec Sa,
Captor Therapeutics Sa,
Ardigen.
Bioceltix's support email address is office@bioceltix.com
Bioceltix's categories are Biotechnology Research
